Skip to main content
Improve Medical Instruments CO., Ltd. logo

Improve Medical Instruments CO., Ltd. — Investor Relations & Filings

Ticker · 300030 ISIN · CNE100000JL3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,954 across all filing types
Latest filing 2018-07-17 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300030

About Improve Medical Instruments CO., Ltd.

https://www.improve-medical.com

Improve Medical Instruments CO., Ltd. focuses on the development, production, and distribution of clinical laboratory and nursing solutions. The core product range includes evacuated blood collection systems, specimen collection and transport media, and laboratory automation equipment. The company also provides medical imaging components and point-of-care testing (POCT) systems. By integrating research and development with advanced manufacturing, the organization supports clinical diagnostics and patient care through high-precision tools designed for healthcare facilities and research laboratories. Its offerings are characterized by a commitment to diagnostic safety and efficiency across global markets.

Recent filings

Filing Released Lang Actions
关于医疗器械产品延续注册的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the renewal of medical device registrations issued by a regulatory authority (Guangdong Food and Drug Administration). It provides details about the registration certificates and their validity periods. The document does not contain financial statements, management discussion, or detailed financial data. It is a regulatory announcement about product registration status, not a financial report or meeting material. The document length is short (861 characters), and it is an announcement of regulatory compliance information. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2018-07-17 Chinese
关于2018年第二季度公司及子公司收到政府补助的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Guangzhou Yangpu Medical Technology Co., Ltd. regarding government subsidies received in the second quarter of 2018. It details the amounts, sources, and accounting treatment of these subsidies. The document is relatively short (3110 characters) and primarily serves to inform shareholders and the public about the receipt and expected impact of government grants. It does not contain comprehensive financial statements or detailed financial analysis typical of quarterly or annual reports. It is not a certification or officer attestation. The content fits best as a regulatory announcement about government subsidies received, which does not fit into more specific categories like Annual Report, Interim Report, or Earnings Release. Therefore, it is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other categories.
2018-07-13 Chinese
2018年半年度业绩预告
Earnings Release Classification · 95% confidence The document is titled as a '2018 半年度业绩预告' which translates to '2018 Half-Year Performance Forecast'. It provides estimated financial results for the period January 1 to June 30, 2018, including expected net profit ranges and explanations for performance changes. It explicitly states that the forecast has not been audited and that detailed financial data will be disclosed in the 2018 half-year financial report. This type of document is a performance forecast or earnings guidance rather than a full interim or quarterly report containing actual financial statements. Therefore, it fits best under the category of Earnings Release (ER), which covers initial announcements of quarterly or periodical financial results with key highlights only. The document length is short and it contains forward-looking estimates rather than comprehensive financial data, so it is not an Interim/Quarterly Report (IR). H1 2018
2018-07-13 Chinese
关于医疗器械注册证变更的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from Guangzhou Yangpu Medical Technology Co., Ltd. regarding a change in the medical device registration certificate issued by the Guangdong Food and Drug Administration. It details the changes in product model, scope, structure, and technical requirements. The document is short (888 characters) and serves as an official notification about regulatory approval changes related to product registration. It does not contain financial data, management changes, voting results, or any report or presentation content. It is not a report publication announcement or certification. The content fits best under a general regulatory announcement category. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2018-07-10 Chinese
公司债券2017年度受托管理事务报告
Audit Report / Information Classification · 95% confidence The document is titled as a "2017年度受托管理事务报告" (2017 Annual Trustee Management Affairs Report) for a company bond issued by Guangzhou Yangpu Medical Technology Co., Ltd. It contains detailed information about the bond issuance, trustee management activities, the issuer's 2017 financial and operating status, use of raised funds, guarantee mechanisms, debt repayment measures, and other related disclosures. The document is comprehensive and focused on the trustee management of a corporate bond, including financial data and operational details for the year 2017. It is not a full annual report (10-K), nor an earnings release or interim report. It is not a proxy, call transcript, or capital update. It is a specialized report related to bond trustee management and compliance with bond issuance regulations. This type of document fits best under the category of Audit Report / Information (AR), as it is a standalone report related to the bond issuance, trustee duties, and financial oversight, but not the full annual report of the company. FY 2017
2018-06-27 Chinese
关于收到企业债券市场融资贴息的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding the receipt of government subsidy funds related to bond market financing interest subsidies. It includes details about the amount received, the accounting treatment, and a reference to a previous announcement. The document is brief (597 characters) and serves as a notification rather than a detailed financial report or audit. It does not contain financial statements or comprehensive financial data. Therefore, it fits best as a Regulatory Filing (RNS), which is a general regulatory announcement category for miscellaneous filings that do not fit other specific categories.
2018-06-26 Chinese

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.